You are here

New production facility for Rohacell in Darmstadt increases capacity

News International-French

5 Feb 2014

The facility enables Evonik to account for the increasing demand and growth strategy for Rohacell.

End of 2013 Evonik Industries AG successfully began operation of its new production facility for Rohacell structural foam at the Darmstadt site, following an investment of approximately six million Euros. The new facility will increase the polymerization capacity at the site by 50%. Due to the extensive automation of polymerization, the cycle times have dropped by almost half.

At the same time, the polymerization process was automated with modern robot technology in many areas. This led to shorter cycle times and therefore, significantly increased capacity.

Rohacell is a structural foam based on polymethacrylimide, which is used in fiber-reinforced composite parts for lightweight applications. The most important market segments are aerospace and lifestyle, as well as automotive engineering and wind energy.

Photo: Robot technology enables automation of Rohacell polymerization at Evonik. The reduced cycle times led to a significant increase in capacity.

About Evonik Industries AG:
Evonik, the creative industrial group from Germany, is a leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. The company benefits specifically from its innovative prowess and integrated technology platforms.

It is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).